Quick Answer
20/20 Biolabs, Inc. reported R&D Expense of $592.6 thousand for fiscal year 2025.
20/20 Biolabs, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $592.6K | -53.0% |
| 2024 | $1.26M | — |
- 20/20 Biolabs, Inc. showed a decrease of -53.0% in R&D Expense compared to the prior fiscal year.
- Over the 2024–2025 period, 20/20 Biolabs, Inc.’s r&d expense has declined by 53.0% (from $1.26 million to $592.6 thousand).
- The most recent figure is from 20/20 Biolabs, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: